Thus, the classical NAFLD progression from steatosis to fibrosis does not completely explain the liver disease in ALMS, and we could suggest the involvement of ALMS1 deficiency in the liver disease of patients with ALMS. The gene discussed is ALMS1; the disease is metabolic dysfunction-associated steatotic liver disease.